Found 12 matching trials
Calcineurin Inhibitor Based Immunosuppression Withdrawal NA Damage and scarring of a transplanted kidney has become the most common cau...
Show More Location
Pediatric Nephrology of Alabama
Learn More & Join Trial
Tocilizumab in Cardiac Transplantation PHASE2 The purpose of this research study is to see if a study drug called Tociliz...
Show More Location
Cedars Sinai Medical Center (CACS)
Learn More & Join Trial
Improved Induction and Maintenance Immunosuppression in Kidney Transplantation PHASE4 This 2 x 2 sequential factorial study evaluates two potential improvements ...
Show More Location
Unversity of Nebraska Medical Center
Learn More & Join Trial
Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal PHASE4 Current therapy to prevent organ rejection relies on the use of calcineurin...
Show More Location
Buffalo General Hospital Multi-Organ Transplant Department
Learn More & Join Trial
Low-dose IL-2 for Treg Expansion and Tolerance (LITE) PHASE4 Regulatory T cells (Tregs) suppress cytopathic immune responses and inhibit...
Show More Location
Alberto Sanchez-Fueyo
Learn More & Join Trial
SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus PHASE4 The aim of this study is to assess the safety and efficacy of corticosteroi...
Show More Location
Royal Prince Alfred Hospital
Learn More & Join Trial
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation PHASE2 The study will compare how well transplanted kidneys work and the response ...
Show More Location
University of California Los Angeles
Learn More & Join Trial
REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy PHASE3 The purpose of this study was, starting from the Italian clinical practice ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure PHASE4 The goal of this clinical trial is to compare the degree of HLA sensitizati...
Show More Location
Hospital Universitario Vall D'Hebron
Learn More & Join Trial
Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients PHASE3 The purpose of this study is to determine if everolimus combined with reduc...
Show More Location
Novartis Investigative Site
Learn More & Join Trial